L
Labgenomics Co Ltd
KOSDAQ:084650
Labgenomics Co Ltd
KOSDAQ:084650
Price:
2 705 KRW
-1.99%
Market Closed
Updated:
May 21, 2024
Section:
Relative Value
The Relative Value of one Labgenomics Co Ltd stock under the Base Case scenario is 1 793.79 KRW. Compared to the current market price of 2 705 KRW, Labgenomics Co Ltd is Overvalued by 34%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
1 793.79
KRW
Overvaluation 34%
L
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Labgenomics Co Ltd Competitors
Labgenomics Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
L
|
Labgenomics Co Ltd
KOSDAQ:084650
|
200.8B KRW | 2.7 | -43 | -116.1 | -15.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
290.6B USD | 5.3 | 48.8 | 13.7 | 21.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
168.7B USD | 5.7 | 44.8 | 18.8 | 31.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD | 11.3 | 28.7 | 24 | 25.1 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108.8B USD | 8.3 | 28.2 | 22.8 | 25.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
134.3B AUD | 6.3 | 36.2 | 21.9 | 27.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
84.6B USD | 3.1 | 174.8 | 8.8 | 11.6 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54B USD | 10.5 | -9 | -10.1 | -9 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
33.7B USD | 3.5 | 28.9 | 14.7 | 18.3 | |
| KR |
|
Celltrion Inc
KRX:068270
|
38.7T KRW | 17.8 | 72.3 | 44.3 | 61 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
